Full Time Equivalent(FTE)

Download

• In the early stages of new drug development, FTE-defined projects  are often used by drug discovery companies to synthesize the required structural fragments and/or potential candidate compounds to accelerate the drug screening process. Medicilon provides comprehensive chemistry research services covering all stages of your project requirements, and customers can work with us through either FFS (Fee for Service) or FTE models.
  Medicilon has a dedicated R&D and project management team. According to customer requirements, it can configure different proportions of R&D staff with different levels of experience to form a joint R&D team with customers to quickly and efficiently solve the challenges of their R&D projects provide regular project progress reports and run project update meetings.
  Moreover, Medicilon can quickly adapt to the client's needs and provide efficient output to ensure the smooth progress of the project. This partnership model is ideal for innovative drug development projects.
• The Medicilon Chemical FTE team can serve clients at different stages of drug development, including:
  Generation and optimization of lead compoundsIdentificationOptimization of lead compounds, synthesis scale-upChemical process studies

• FTE Collaboration Model
  This collaboration model allows for flexible adjustment of R&D staffing, experimental protocols, and project priorities based on client and project needs.
• FTE Service Advantage
  The research department will communicate with the customer when problems are encountered in the R&D process and propose solutions to solve them. The FTE team can not only synthesize according to the synthesis line designed by the customer but can also design the synthesis line according to the customer's concept.
  Flexible responses based on project requirements makes progress clear and controllable and provides exclusive synthesis circuit design and problem solving, all of which reflect the service advantages of the Medicilon FTE team.
• FTE Service Scope

  

  Medicinal Chemistry

  

  Synthetic Chemistry

  

  Analytical Chemistry

• FTE Service Case
  Oriented by customer needs, with the aim of innovative drug research, the Medicilon Chemical FTE team has assisted many companies in drug development.

  

  RG001 tablet is a new SHP2 allosteric inhibitor independently developed by Ringene based on structural biology and drug metabolism-oriented drug design methods. Medicilon provides a range of preclinical services from drug targets to IND filing in the development of RG001 tablets to enter the clinical trial phase, including drug discovery, pharmaceutical research, and pre-clinical research (drug efficacy and safety evaluations).

  Learn more

  

  ABM Therapeutics has cooperated with Medicilon since 2016. During this time, Medicilon FTE helped ABM Therapeutics discover the clinical candidate compound (PCC) ABM-1310 (the drug is currently undergoing clinical trials in China and the United States in parallel).

  MindRank, is an AI pharmaceutical company. In the cooperation with Medicilon’s FTE, it has utilised the advantages of AI design combined with laboratory confirmation. In a short-term, low-cost and high-efficiency working mode, Medicilon completed the cooperative project with high quality, and was awarded the "2021 Excellent Team Award" by the customer.

  Learn more

Inquire

Relevant laboratories

• 
• 
• 
• 
• 
• 
• 
• 
• 

Relevant articles